Your browser doesn't support javascript.
loading
GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis.
Moore, L E; Baris, D R; Figueroa, J D; Garcia-Closas, M; Karagas, M R; Schwenn, M R; Johnson, A T; Lubin, J H; Hein, D W; Dagnall, C L; Colt, J S; Kida, M; Jones, M A; Schned, A R; Cherala, S S; Chanock, S J; Cantor, K P; Silverman, D T; Rothman, N.
Afiliación
  • Moore LE; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20852, USA. moorele@mail.nih.gov
Carcinogenesis ; 32(2): 182-9, 2011 Feb.
Article en En | MEDLINE | ID: mdl-21037224

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Arilamina N-Acetiltransferasa / Neoplasias de la Vejiga Urinaria / Fumar / Glutatión Transferasa Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies / Systematic_reviews Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Carcinogenesis Año: 2011 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Arilamina N-Acetiltransferasa / Neoplasias de la Vejiga Urinaria / Fumar / Glutatión Transferasa Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies / Systematic_reviews Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Carcinogenesis Año: 2011 Tipo del documento: Article País de afiliación: Estados Unidos